China Hepatitis B Vaccines Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Hepatitis B Vaccines Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Hepatitis B Vaccines Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Hepatitis B Vaccines Overall Market Size
2.1 China Hepatitis B Vaccines Market Size: 2021 VS 2027
2.2 China Hepatitis B Vaccines Revenue, Prospects & Forecasts: 2016-2027
2.3 China Hepatitis B Vaccines Sales: 2016-2027
3 Company Landscape
3.1 Top Hepatitis B Vaccines Players in China Market
3.2 Top China Hepatitis B Vaccines Companies Ranked by Revenue
3.3 China Hepatitis B Vaccines Revenue by Companies
3.4 China Hepatitis B Vaccines Sales by Companies
3.5 China Hepatitis B Vaccines Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Hepatitis B Vaccines Companies in China Market, by Revenue in 2020
3.7 Manufacturers Hepatitis B Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatitis B Vaccines Players in China Market
3.8.1 List of Tier 1 Hepatitis B Vaccines Companies in China
3.8.2 List of Tier 2 and Tier 3 Hepatitis B Vaccines Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Hepatitis B Vaccines Market Size Markets, 2021 & 2027
4.1.2 Yeast Derived
4.1.3 CHO Derived
4.2 By Type - China Hepatitis B Vaccines Revenue & Forecasts
4.2.1 By Type - China Hepatitis B Vaccines Revenue, 2016-2021
4.2.2 By Type - China Hepatitis B Vaccines Revenue, 2022-2027
4.2.3 By Type - China Hepatitis B Vaccines Revenue Market Share, 2016-2027
4.3 By Type - China Hepatitis B Vaccines Sales & Forecasts
4.3.1 By Type - China Hepatitis B Vaccines Sales, 2016-2021
4.3.2 By Type - China Hepatitis B Vaccines Sales, 2022-2027
4.3.3 By Type - China Hepatitis B Vaccines Sales Market Share, 2016-2027
4.4 By Type - China Hepatitis B Vaccines Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Hepatitis B Vaccines Market Size, 2021 & 2027
5.1.2 Children
5.1.3 Adult
5.2 By Application - China Hepatitis B Vaccines Revenue & Forecasts
5.2.1 By Application - China Hepatitis B Vaccines Revenue, 2016-2021
5.2.2 By Application - China Hepatitis B Vaccines Revenue, 2022-2027
5.2.3 By Application - China Hepatitis B Vaccines Revenue Market Share, 2016-2027
5.3 By Application - China Hepatitis B Vaccines Sales & Forecasts
5.3.1 By Application - China Hepatitis B Vaccines Sales, 2016-2021
5.3.2 By Application - China Hepatitis B Vaccines Sales, 2022-2027
5.3.3 By Application - China Hepatitis B Vaccines Sales Market Share, 2016-2027
5.4 By Application - China Hepatitis B Vaccines Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Overview
6.1.3 GSK Hepatitis B Vaccines Sales and Revenue in China Market (2016-2021)
6.1.4 GSK Hepatitis B Vaccines Product Description
6.1.5 GSK Recent Developments
6.2 NCPC
6.2.1 NCPC Corporation Information
6.2.2 NCPC Overview
6.2.3 NCPC Hepatitis B Vaccines Sales and Revenue in China Market (2016-2021)
6.2.4 NCPC Hepatitis B Vaccines Product Description
6.2.5 NCPC Recent Developments
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Overview
6.3.3 Merck Hepatitis B Vaccines Sales and Revenue in China Market (2016-2021)
6.3.4 Merck Hepatitis B Vaccines Product Description
6.3.5 Merck Recent Developments
6.4 Bio Kangtai
6.4.1 Bio Kangtai Corporation Information
6.4.2 Bio Kangtai Overview
6.4.3 Bio Kangtai Hepatitis B Vaccines Sales and Revenue in China Market (2016-2021)
6.4.4 Bio Kangtai Hepatitis B Vaccines Product Description
6.4.5 Bio Kangtai Recent Developments
6.5 Dynavax
6.5.1 Dynavax Corporation Information
6.5.2 Dynavax Overview
6.5.3 Dynavax Hepatitis B Vaccines Sales and Revenue in China Market (2016-2021)
6.5.4 Dynavax Hepatitis B Vaccines Product Description
6.5.5 Dynavax Recent Developments
6.6 Hissen
6.6.1 Hissen Corporation Information
6.6.2 Hissen Overview
6.6.3 Hissen Hepatitis B Vaccines Sales and Revenue in China Market (2016-2021)
6.6.4 Hissen Hepatitis B Vaccines Product Description
6.6.5 Hissen Recent Developments
6.7 KM Biologics
6.7.1 KM Biologics Corporation Information
6.7.2 KM Biologics Overview
6.7.3 KM Biologics Hepatitis B Vaccines Sales and Revenue in China Market (2016-2021)
6.7.4 KM Biologics Hepatitis B Vaccines Product Description
6.7.5 KM Biologics Recent Developments
6.8 LG Life Sciences
6.8.1 LG Life Sciences Corporation Information
6.8.2 LG Life Sciences Overview
6.8.3 LG Life Sciences Hepatitis B Vaccines Sales and Revenue in China Market (2016-2021)
6.8.4 LG Life Sciences Hepatitis B Vaccines Product Description
6.8.5 LG Life Sciences Recent Developments
6.9 Serum Institute
6.9.1 Serum Institute Corporation Information
6.9.2 Serum Institute Overview
6.9.3 Serum Institute Hepatitis B Vaccines Sales and Revenue in China Market (2016-2021)
6.9.4 Serum Institute Hepatitis B Vaccines Product Description
6.9.5 Serum Institute Recent Developments
7 China Hepatitis B Vaccines Production Capacity, Analysis
7.1 China Hepatitis B Vaccines Production Capacity, 2016-2027
7.2 Hepatitis B Vaccines Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Hepatitis B Vaccines Supply Chain Analysis
9.1 Hepatitis B Vaccines Industry Value Chain
9.2 Hepatitis B Vaccines Upstream Market
9.3 Hepatitis B Vaccines Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Hepatitis B Vaccines Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Hepatitis B Vaccines in China Market
Table 2. Top Hepatitis B Vaccines Players in China Market, Ranking by Revenue (2019)
Table 3. China Hepatitis B Vaccines Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Hepatitis B Vaccines Revenue Share by Companies, 2016-2021
Table 5. China Hepatitis B Vaccines Sales by Companies, (M Doses), 2016-2021
Table 6. China Hepatitis B Vaccines Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Hepatitis B Vaccines Price (2016-2021) & (USD/Doses)
Table 8. Manufacturers Hepatitis B Vaccines Product Type
Table 9. List of Tier 1 Hepatitis B Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Hepatitis B Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Yeast Derived
Table 12. Major Manufacturers of CHO Derived
Table 13. By Type - China Hepatitis B Vaccines Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Hepatitis B Vaccines Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Hepatitis B Vaccines Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Hepatitis B Vaccines Sales (M Doses), 2016-2021
Table 17. By Type - China Hepatitis B Vaccines Sales (M Doses), 2022-2027
Table 18. By Application - China Hepatitis B Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Hepatitis B Vaccines Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Hepatitis B Vaccines Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Hepatitis B Vaccines Sales (M Doses), 2016-2021
Table 22. By Application - China Hepatitis B Vaccines Sales (M Doses), 2022-2027
Table 23. GSK Corporation Information
Table 24. GSK Description and Major Businesses
Table 25. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 26. GSK Hepatitis B Vaccines Product
Table 27. GSK Recent Developments
Table 28. NCPC Corporation Information
Table 29. NCPC Description and Major Businesses
Table 30. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 31. NCPC Hepatitis B Vaccines Product
Table 32. NCPC Recent Developments
Table 33. Merck Corporation Information
Table 34. Merck Description and Major Businesses
Table 35. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 36. Merck Hepatitis B Vaccines Product
Table 37. Merck Recent Developments
Table 38. Bio Kangtai Corporation Information
Table 39. Bio Kangtai Description and Major Businesses
Table 40. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 41. Bio Kangtai Hepatitis B Vaccines Product
Table 42. Bio Kangtai Recent Developments
Table 43. Dynavax Corporation Information
Table 44. Dynavax Description and Major Businesses
Table 45. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 46. Dynavax Hepatitis B Vaccines Product
Table 47. Dynavax Recent Developments
Table 48. Hissen Corporation Information
Table 49. Hissen Description and Major Businesses
Table 50. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 51. Hissen Hepatitis B Vaccines Product
Table 52. Hissen Recent Developments
Table 53. KM Biologics Corporation Information
Table 54. KM Biologics Description and Major Businesses
Table 55. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 56. KM Biologics Hepatitis B Vaccines Product
Table 57. KM Biologics Recent Developments
Table 58. LG Life Sciences Corporation Information
Table 59. LG Life Sciences Description and Major Businesses
Table 60. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 61. LG Life Sciences Hepatitis B Vaccines Product
Table 62. LG Life Sciences Recent Developments
Table 63. Serum Institute Corporation Information
Table 64. Serum Institute Description and Major Businesses
Table 65. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 66. Serum Institute Hepatitis B Vaccines Product
Table 67. Serum Institute Recent Developments
Table 68. Hepatitis B Vaccines Production Capacity (M Doses) of Key Manufacturers in China Market, 2019-2021 (M Doses)
Table 69. China Hepatitis B Vaccines Capacity Market Share of Key Manufacturers, 2019-2021
Table 70. Hepatitis B Vaccines Market Opportunities & Trends in China Market
Table 71. Hepatitis B Vaccines Market Drivers in China Market
Table 72. Hepatitis B Vaccines Market Restraints in China Market
Table 73. Hepatitis B Vaccines Raw Materials
Table 74. Hepatitis B Vaccines Raw Materials Suppliers in China Market
Table 75. Typical Hepatitis B Vaccines Downstream
Table 76. Hepatitis B Vaccines Downstream Clients in China Market
Table 77. Hepatitis B Vaccines Distributors and Sales Agents in China Market
List of FiguresFigure 1. Hepatitis B Vaccines Product Picture
Figure 2. Hepatitis B Vaccines Segment by Type
Figure 3. Hepatitis B Vaccines Segment by Application
Figure 4. China Hepatitis B Vaccines Market Overview: 2020
Figure 5. China Hepatitis B Vaccines Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Hepatitis B Vaccines Revenue, 2016-2027 (US$, Mn)
Figure 7. Hepatitis B Vaccines Sales in China Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Hepatitis B Vaccines Revenue in 2020
Figure 9. Yeast Derived Product Picture
Figure 10. CHO Derived Product Picture
Figure 11. By Type - China Hepatitis B Vaccines Sales Market Share, 2016-2027
Figure 12. By Type - China Hepatitis B Vaccines Revenue Market Share, 2016-2027
Figure 13. By Type - China Hepatitis B Vaccines Price (USD/Doses), 2016-2027
Figure 14. Children
Figure 15. Adult
Figure 16. By Application - China Hepatitis B Vaccines Sales Market Share, 2016-2027
Figure 17. By Application - China Hepatitis B Vaccines Revenue Market Share, 2016-2027
Figure 18. By Application - China Hepatitis B Vaccines Price (USD/Doses), 2016-2027
Figure 19. GSK Hepatitis B Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. NCPC Hepatitis B Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Merck Hepatitis B Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Bio Kangtai Hepatitis B Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Dynavax Hepatitis B Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Hissen Hepatitis B Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. KM Biologics Hepatitis B Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. LG Life Sciences Hepatitis B Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Serum Institute Hepatitis B Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. China Hepatitis B Vaccines Production Capacity (M Doses), 2016-2027
Figure 29. Hepatitis B Vaccines Industry Value Chain
Figure 30. Marketing Channels